Neoplasm Drugs Flashcards
Cell cycle specific neoplasm drugs
Vinca alkaloids Anti-metabolites Taxanes Phodophyllotoxins Bleomycin Aspariginases
Hyperacute graft rejection
- Mechanism: Pre-formed antibodies and complimenting activation
- target: RBC antigens
- pathology: thrombosis and ischemia
- time course:
Non-cell cycle specific neoplasm drugs
Classic alkylating agents Dactinomycin Anthracyclins Nitroureases Mitomycin
Basics: Antimetabolites- methotrexate
- folate/folinate analog -> inhibits DHFR
- dose dependent toxicities (see immunopharm for list)
- can be given intrathecally for trt of carcinomatous meningitis
Antimetabolites: plant alkaloids
M-phase specific: e.g. Vincristine, Vineblastine, ninorebine
- microtubule polymerization inhibitor: inhibits assembly
- highly immunosuppressive
- neurotoxic
Taxanes: taxman, records, pennies
Paclitaxel, docetaxel
- MOA: interfere with mitotic spindle by preventing disassembly
- solid tumors
- neutropenias, tcytopenia, neuropathy
Rescue therapy
Levucorin: methotrexate
Mesna: traps acrolein byproduct of cyclophosphamide
Dexrazoxane: inhibits ROS in anthracyclins
Alkylators: (3)
Cyclophosphamide, chlorambucil, mechlorethamine
(Have chlorine/phosphate group)
- resistance is a result of trapping, decreasing drug permeability, and DNA repair
Mechloramine
Alkylating agent
- converts to reactive cytotoxic agent in the body
- hodgkins and non-hodgkins lymphoma
- vesicant
Platinum analogs
Cisplatin, carboplatin, oxaplatin
- testicular carcinomas, bladder, ovary and lung
- hematoxic, neurotoxic, nephrotoxic
Procarbazine
Forms H2O2
- orally active
- H/NH lymphomas
- inhibits MAO, and has a disulfiram like rxn. Nephro and neurotoxic as well
Mercaptopurine and thioguanine
Both inhibit HGPRTases -> stop purine synthesis
- high first pass metabolism
- marrow suppression is dose limited, it is hepatotoxic.
5-FU
Inhibition of thymadylate synthetase
- widely distributed including CSF
- lots of chemotherapeutic uses
- low toxicity: alopecia, GI distress and myelosupression
TRK inhibitors: Nibs
imatinib, Disatinib, Nilotinib - MOA: block BCR-ABL tyrosine Kinase activity - CML - Heart failure, myalgia, edema (In Philly they show off their nibs)
Gemcitabine
- mOA: Gemcitabine di and triphosphate inhibit ribonucleotide reductase
- non hodge/small cell lung cancer, bladder, pancreatic cancers
- normal 3 with some pulmonary toxicity